News about Drug Discovery & Development

Union Health Minister Inaugurates CDSCO Sub Zonal Office and Central Drug Testing Laboratory in MP

Dr. Mansukh Mandaviya, Union Minister of Health and Family Welfare inaugurated the Central Drugs Standard Control Organization (CDSCO) Sub Zonal office and Central Drug Testing Laboratory (CDTL) in Indore, Madhya Pradesh.

Drug Discovery & Development | 08/01/2024 | By Manvi |  1046

BridGene Biosciences Establishes Strategic Collaboration with Galapagos to Discover Small Molecule Drugs for Oncology Targets

Under the collaboration, BridGene will use its chemoproteomics platform, IMTAC™, to discover novel small molecule drug candidates against the collaboration targets.

Drug Discovery & Development | 05/01/2024 | By Manvi |  632

Boehringer Ingelheim Inks Second Pact with 3T Biosciences to Develop Cancer Immunotherapies

This second research partnership with 3T builds on the successful completion of the initial research partnership announced last year by the two companies.

Drug Discovery & Development | 05/01/2024 | By Manvi |  664

PillSafe Launches 'Smart' Pill Bottle for Prescription Drugs

PillSafe® uses new disruptive technology, a groundbreaking economical “smart” pill bottle for prescription drugs, designed by doctors to ensure safety and compliance with medication in the fight against addictive drugs.

Drug Discovery & Development | 04/01/2024 | By Manvi |  575

Venus Remedies Secures Marketing Approval from Israel, Colombia for Two Oncology Drugs

Building on its international presence in the oncology space, Venus Remedies has secured marketing authorisation for docetaxel from Israel and cytarabine from Colombia.

Drug Discovery & Development | 29/12/2023 | By Manvi |  692

SEQSTER Launches CoRD Accelerating Drug Discovery and Deep Insights for Pharma

This innovative tool parses, standardizes, and transforms data into a clean, common form, eliminating barriers to comprehensive healthcare insights.

Drug Discovery & Development | 12/12/2023 | By Manvi |  294

Lupin Launches World's First Fixed-dose Triple Combination Drug

Lupin Vilfuro-G® is the only FDC that uniquely combines Vilanterol, Fluticasone Furoate and Glycopyrronium Bromide, for the long-term management and treatment of moderate to severe COPD.

Drug Discovery & Development | 27/11/2023 | By Manvi |  767

Lupin Gets Approval from US FDA for Pitavastatin Tablets

Pitavastatin Tablets are indicated as an adjunct to diet to reduce low-density lipoprotein cholesterol (LDL-C) in Adults with primary hyperlipidemia, Adults and pediatric patients aged 8 years and older with heterozygous familial hypercholesterolemia (HeFH).

Drug Discovery & Development | 22/11/2023 | By Manvi |  482

Qubit Pharmaceuticals Announces Euro 4.5 Mn Investment in New Drug Discovery Platform

The initiative is supported by Bpifrance with a total investment of €2 million via the Investissements d'Avenir and France 2030 programs.

Drug Discovery & Development | 20/11/2023 | By Manvi |  707

Venus Remedies Granted Market Authorization for Bleomycin 15,000 IU in UK

This remarkable milestone not only expands the pharma giant's global presence but also underscores its commitment to advancing cancer care with innovative solutions.

Drug Discovery & Development | 30/10/2023 | By Manvi |  749